Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022

    Apr 7, 2022, 17:59 PM by
    Full story
  • Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

    Apr 7, 2022, 17:59 PM by
    Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform
    Full story
  • COMPREHENSIVE OFFERING OF LIQUID STABLE BIO-SYNTHETIC REFERENCE MATERIALS FOR URINE CHEMISTRIES NOW AVAILABLE FROM VERICHEM

    Apr 7, 2022, 17:59 PM by
    VERICHEM now offers clinical laboratorians a comprehensive range of liquid stable and ready-to-use biosynthetic clinical reference materials designed for system calibration and calibration verification testing procedures with urine chemistry assays.
    Full story
  • CluePoints Continues Impressive Global Growth with Three New Senior Appointments

    Apr 7, 2022, 17:59 PM by
    CluePoints Continues Impressive Global Growth with Three New Senior Appointments The company welcomes new VP Marketing, VP People, and VP Business Operations to its expanding team King of Prussia, PA – 5th April, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations.
    Full story
  • WCG Unveils Strategic Alliance Program for CROs

    Apr 7, 2022, 17:59 PM by
    Leading CROs Increase Adoption of WCG's Suite of Solutions Enabling Connectivity to Top Clinical Trial Sites Via Unrivaled Technology and Staffing Solutions Global Program Drives Collaboration to Increase Efficiency and Reduce Burden on Investigative Sites, Accelerating Clinical Trials Sponsored by Pharmaceutical, Biotech and Medical Device Companies
    Full story
  • Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market

    Apr 7, 2022, 17:59 PM by
    Seasoned Healthcare Industry Executive Joins Organization to Lead Business Development, Acquisitions, and Expansion into New Markets
    Full story
  • Rho Hires Global VP of Quality Assurance to Support International Expansion following Acquisition

    Apr 7, 2022, 17:59 PM by
    Full story
  • Epic Selects Lyniate for Integration within the Epic Garden Plot Offering

    Apr 7, 2022, 17:59 PM by
    Full story
  • Novel drug from Neuro-Bio effective in a mouse model of Alzheimer's Disease

    Apr 7, 2022, 17:59 PM by
    Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease.
    Full story
  • PubHive Integrates Unpaywall Into PubHive Navigator

    Apr 7, 2022, 17:59 PM by
    Cloud software platform PubHive Navigator saves time for life science teams by expanding journal article access via the platform’s research literature workflow module Fetch
    Full story
  • Alfa Chemistry Refreshed Its Website for the Supply of MOF Chemicals

    Apr 7, 2022, 17:59 PM by
    Earlier this year, Alfa Chemistry, a well-established chemical supplier based in New York, announced its decision to further optimize its supply of MOF chemicals, a new material that has huge potentials in fields like gas storage, separation, and catalysis. Now the company has completed the website refresh work and introduced a new brand logo. All these efforts are made in the hope of bringing better customer experience and more convenient website searching.
    Full story
  • CD Formulation Announces to Offer Nitrosamine Impurities Analysis Service for Drug Formulation Projects

    Apr 7, 2022, 17:59 PM by
    Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.
    Full story
  • Summarization of the POC Blood Gas and Electrolyte, including the initiatives undertaken by the organizations for its improvisation

    Apr 7, 2022, 17:59 PM by
    Global POC Blood Gas and Electrolyte Market share accounted for up to US$1.95 Bn. It is predicted to reach approximately US$3.6 Bn by 2028, with a steady CAGR of 7.89% throughout the time frame of 2020-2028.
    Full story
  • Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

    Apr 7, 2022, 17:59 PM by
    Full story
  • Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

    Apr 7, 2022, 17:59 PM by
    Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV).
    Full story
  • Scientists Finally Finish The Quest For A Gapless Human Genome

    Apr 7, 2022, 01:00 AM by User Not Found
    Bio-IT World | There was no escaping last week’s announcement that the final 8% of the human genome—the equivalent of an entire DNA chromosome—has been sequenced, filling a gap left nearly 20 years after the Human Genome Project declared victory. More than 100 researchers from around the world collaborated on the initiative and many of them, and the institutions they represent, have weighed in on the feat.
    Full story
  • AI Betting Agents Weigh In On Reproducibility Of Research Findings

    Apr 5, 2022, 01:00 AM by User Not Found
    Bio-IT World | Penn State researchers have created synthetic “prediction markets” for speculating on the replicability of published studies with unparalleled accuracy. When betting on published social and behavioral science papers, about 90% of the time bot agents correctly “bought” papers that were eventually reproduced.
    Full story
  • Follow the Money: Single-Cell Analysis, Spatial Biology, Drug-Resistant Infection Treatments, 3D Genomics

    Mar 31, 2022, 01:00 AM by User Not Found
    Bio-IT World | Funds raised for life science company investment, AI-powered single-cell analysis, spatial biology, ML-based discovery of new anti-infectives, and real-time supply chain operations analysis.
    Full story
  • New Illumina Accelerator Start-Ups, Blood Test for Liver Cancer, Several New Collaborations, Software Offerings, More

    Mar 30, 2022, 01:00 AM by User Not Found
    Bio-IT World | A genomic network model is used to identify aurora kinase inhibitor-sensitive lung tumors, new Illumina Accelerator start-ups are announced, AI algorithms are being used to improve prostate cancer identification and treatment, and a blood-based DNA methylation test can detect liver cancer
    Full story
  • Digitization Vs. Digital Transformation at Alnylam

    Mar 29, 2022, 09:00 AM by User Not Found
    Bio-IT World | Jim Bilotta found his home in orphan diseases early in his career, driven by both personal experience and the “unbelievable” impact on patients and their families. Today, as Chief Information Officer, head of IT, at Alnylam, he is still pursuing that impact. In the latest episode of Bio-IT World’s Trends from the Trenches podcast, Bilotta and Trends from the Trenches host, Stan Gloss, discuss digital transformation at Alnylam, and how Bilotta views the distinction between digitization and digital transformation.
    Full story
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149 (current)
  • 150
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy